The frequency and efficacy of genetic testing in individuals with scimitar syndrome
BACKGROUND: Scimitar syndrome is a rare CHD composed of partial anomalous pulmonary venous connection from the right lung, via a scimitar vein, to the inferior vena cava rather than the left atrium. Genetic conditions associated with scimitar syndrome have not been well investigated at present.
METHODS: Our study included patients with scimitar syndrome diagnosed at Texas Children's Hospital from January 1987 to July 2020. Medical records were evaluated to determine if genetic testing was performed, including chromosomal microarray analysis or whole-exome sequencing. Copy number variants identified as pathogenic/likely pathogenic and variants of unknown significance were collected. Analyses of cardiac and extracardiac findings were performed via chart review.
RESULTS: Ninety-eight patients were identified with scimitar syndrome, 89 of which met inclusion criteria. A chromosome analysis or chromosomal microarray analysis was performed in 18 patients (20%). Whole-exome sequencing was performed in six patients following negative chromosomal microarray analysis testing. A molecular genetic diagnosis was made in 7 of 18 cases (39% of those tested). Ninety-six per cent of the cohort had some type of extracardiac finding, with 43% having asthma and 20% having a gastrointestinal pathology. Of the seven patients with positive genetic testing, all had extracardiac anomalies with all but one having gastrointestinal findings and 30% having congenital diaphragmatic hernia.
CONCLUSIONS: Genetic testing revealed an underlying diagnosis in roughly 40% of those tested. Given the relatively high prevalence of pathogenic variants, we recommend chromosomal microarray analysis and whole-exome sequencing for patients with scimitar syndrome and extracardiac defects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Cardiology in the young - 32(2022), 4 vom: 01. Apr., Seite 550-557 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fick, Tyler A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CHD |
|---|
| Anmerkungen: |
Date Completed 09.05.2022 Date Revised 02.04.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/S1047951121002535 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327570822 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327570822 | ||
| 003 | DE-627 | ||
| 005 | 20231225201057.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S1047951121002535 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1091.xml |
| 035 | |a (DE-627)NLM327570822 | ||
| 035 | |a (NLM)34210367 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fick, Tyler A |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The frequency and efficacy of genetic testing in individuals with scimitar syndrome |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.05.2022 | ||
| 500 | |a Date Revised 02.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Scimitar syndrome is a rare CHD composed of partial anomalous pulmonary venous connection from the right lung, via a scimitar vein, to the inferior vena cava rather than the left atrium. Genetic conditions associated with scimitar syndrome have not been well investigated at present | ||
| 520 | |a METHODS: Our study included patients with scimitar syndrome diagnosed at Texas Children's Hospital from January 1987 to July 2020. Medical records were evaluated to determine if genetic testing was performed, including chromosomal microarray analysis or whole-exome sequencing. Copy number variants identified as pathogenic/likely pathogenic and variants of unknown significance were collected. Analyses of cardiac and extracardiac findings were performed via chart review | ||
| 520 | |a RESULTS: Ninety-eight patients were identified with scimitar syndrome, 89 of which met inclusion criteria. A chromosome analysis or chromosomal microarray analysis was performed in 18 patients (20%). Whole-exome sequencing was performed in six patients following negative chromosomal microarray analysis testing. A molecular genetic diagnosis was made in 7 of 18 cases (39% of those tested). Ninety-six per cent of the cohort had some type of extracardiac finding, with 43% having asthma and 20% having a gastrointestinal pathology. Of the seven patients with positive genetic testing, all had extracardiac anomalies with all but one having gastrointestinal findings and 30% having congenital diaphragmatic hernia | ||
| 520 | |a CONCLUSIONS: Genetic testing revealed an underlying diagnosis in roughly 40% of those tested. Given the relatively high prevalence of pathogenic variants, we recommend chromosomal microarray analysis and whole-exome sequencing for patients with scimitar syndrome and extracardiac defects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CHD | |
| 650 | 4 | |a Scimitar syndrome | |
| 650 | 4 | |a cardiogenetics | |
| 650 | 4 | |a pulmonary vein | |
| 700 | 1 | |a Scott, Daryl A |e verfasserin |4 aut | |
| 700 | 1 | |a Lupo, Philip J |e verfasserin |4 aut | |
| 700 | 1 | |a Weigand, Justin |e verfasserin |4 aut | |
| 700 | 1 | |a Morris, Shaine A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiology in the young |d 1991 |g 32(2022), 4 vom: 01. Apr., Seite 550-557 |w (DE-627)NLM091548926 |x 1467-1107 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2022 |g number:4 |g day:01 |g month:04 |g pages:550-557 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/S1047951121002535 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2022 |e 4 |b 01 |c 04 |h 550-557 | ||